Literature DB >> 16289911

Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.

Michael Pinkawa1, Karin Fischedick, Branka Asadpour, Bernd Gagel, Marc D Piroth, Michael J Eble.   

Abstract

PURPOSE: To assess the impact of dose-volume histogram parameters on low-grade toxicity after radiotherapy for prostate cancer. METHODS AND MATERIALS: Eighty patients have been surveyed prospectively before (time A), at the last day (B), 2 months after (C), and 16 months (median) after (D) radiotherapy (70.2 Gy) using a validated questionnaire (Expanded Prostate Cancer Index Composite). Dose-volume histograms were correlated with urinary and bowel function/bother scores.
RESULTS: The initial bladder volume and the percentage of the bladder volume receiving 10%-90% of the prescription dose significantly correlated with urinary function/bother scores (significant cutoff levels found for all dose levels). Pain with urination proved to be mainly an acute problem, subsiding faster for patients with larger bladder volumes and smaller volumes inside particular isodose lines. At time D, persisting problems with smaller initial bladder volumes were a weak stream and an increased frequency of urination. Though bladder volume and planning target volume both independently have an influence on dose-volume histogram parameters for the bladder, bladder volume plays the decisive role for urinary toxicity.
CONCLUSIONS: The patient's ability to fill the bladder has a major impact on the dose-volume histogram and both acute and late urinary toxicity.

Entities:  

Mesh:

Year:  2005        PMID: 16289911     DOI: 10.1016/j.ijrobp.2005.09.003

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.

Authors:  Matthias Guckenberger; Sami Ok; Bülent Polat; Reinhart A Sweeney; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

2.  Physical and clinical implications of radiotherapy treatment of prostate cancer using a full bladder protocol.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Dario Zerini; Federica Cattani; Flavia Serafini; Rosa Luraschi; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

3.  Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.

Authors:  A Zapatero; M Roch; D Büchser; P Castro; L Fernández-Banda; G Pozo; O Liñán; C Martin de Vidales; A Cruz-Conde; F García-Vicente
Journal:  Clin Transl Oncol       Date:  2017-04-03       Impact factor: 3.405

4.  Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study.

Authors:  Michael Pinkawa; Richard Holy; Marc D Piroth; Karin Fischedick; Sandra Schaar; Dalma Székely-Orbán; Michael J Eble
Journal:  Radiat Oncol       Date:  2010-04-08       Impact factor: 3.481

5.  Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.

Authors:  Michael Pinkawa; Marc D Piroth; Karin Fischedick; Richard Holy; Jens Klotz; Sandra Nussen; Barbara Krenkel; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

6.  Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion.

Authors:  Michael Pinkawa; Martin Pursch-Lee; Branka Asadpour; Bernd Gagel; Marc D Piroth; Jens Klotz; Sandra Nussen; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

7.  Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy.

Authors:  Alexandra J Stewart; Robert A Cormack; Hang Lee; Li Xiong; Jorgen L Hansen; Desmond A O'Farrell; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

8.  Impact of bladder volume on acute genitourinary toxicity in intensity modulated radiotherapy for localized and locally advanced prostate cancer.

Authors:  Arne Grün; Michael Kawgan-Kagan; David Kaul; Harun Badakhshi; Carmen Stromberger; Volker Budach; Dirk Böhmer
Journal:  Strahlenther Onkol       Date:  2018-11-15       Impact factor: 3.621

9.  Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding.

Authors:  Michael Pinkawa; Marc D Piroth; Karin Fischedick; Sandra Nussen; Jens Klotz; Richard Holy; Michael J Eble
Journal:  Radiat Oncol       Date:  2009-09-21       Impact factor: 3.481

10.  Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment.

Authors:  Michael Pinkawa; Karin Fischedick; Bernd Gagel; Marc D Piroth; Branka Asadpour; Jens Klotz; Holger Borchers; Gerhard Jakse; Michael J Eble
Journal:  BMC Cancer       Date:  2009-08-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.